Free Trial

Morgan Stanley (MS) Stock Forecast & Price Target

Morgan Stanley logo
$136.21 -1.09 (-0.79%)
As of 02:25 PM Eastern
This is a fair market value price provided by Polygon.io. Learn more.

Morgan Stanley - Analysts' Recommendations and Stock Price Forecast (2025)

MarketBeat calculates consensus analyst ratings for stocks using the most recent rating from each Wall Street analyst that has rated a stock within the last twelve months. Each analyst's rating is normalized to a standardized rating score of 1 (sell), 2 (hold), 3 (buy) or 4 (strong buy). Analyst consensus ratings scores are calculated using the mean average of the number of normalized sell, hold, buy and strong buy ratings from Wall Street analysts. Each stock's consensus analyst rating is derived from its calculated consensus ratings score (0 to .5 = Strong Sell, .5 to 1 = Sell, 1 to 1.5 = Reduce, 1.5 to 2.5 = Hold, 2.5 to 3.0 = Moderate Buy, 3.0 to 3.5 = Buy, >3.5 = Strong Buy). MarketBeat's consensus price targets are a mean average of the most recent available price targets set by each analyst that has set a price target for the stock in the last twelve months. MarketBeat's consensus ratings and consensus price targets may differ from those calculated by other firms due to differences in methodology and available data.

Consensus Rating

Sell
0
Hold
11
Buy
6

Based on 17 Wall Street analysts who have issued ratings for Morgan Stanley in the last 12 months, the stock has a consensus rating of "Hold." Out of the 17 analysts, 11 have given a hold rating, and 6 have given a buy rating for MS.

Consensus Price Target

$131.27
-3.63% Downside
According to the 17 analysts' twelve-month price targets for Morgan Stanley, the average price target is $131.27. The highest price target for MS is $156.00, while the lowest price target for MS is $105.00. The average price target represents a forecasted downside of -3.63% from the current price of $136.21.
Get the Latest News and Ratings for MS and Related Stocks

Enter your email address to receive the latest news and analysts' ratings for Morgan Stanley and its competitors.

Sign Up

MS Analyst Ratings Over Time

TypeCurrent Forecast
1/23/24 to 1/22/25
1 Month Ago
12/24/23 to 12/23/24
3 Months Ago
10/25/23 to 10/24/24
1 Year Ago
1/23/23 to 1/23/24
Strong Buy
0 Strong Buy rating(s)
0 Strong Buy rating(s)
1 Strong Buy rating(s)
1 Strong Buy rating(s)
Buy
6 Buy rating(s)
6 Buy rating(s)
7 Buy rating(s)
6 Buy rating(s)
Hold
11 Hold rating(s)
11 Hold rating(s)
10 Hold rating(s)
12 Hold rating(s)
Sell
0 Sell rating(s)
0 Sell rating(s)
1 Sell rating(s)
0 Sell rating(s)
Consensus Price Target$131.27$121.80$109.24$94.40
Forecasted Upside-3.63% Downside-2.13% Downside-8.34% Downside8.83% Upside
Consensus Rating
Hold
Hold
Hold
Hold

MS Analyst Recommendations By Month

The chart below shows how a company's ratings by analysts have changed over time. Each bar represents the previous year of ratings for that month. Within each bar, the sell ratings are shown in red, the hold ratings are shown in yellow, the buy ratings are shown in green, and the strong buy ratings are shown in dark green.
Skip Chart & View Analyst Rating History

MS Price Targets by Month

The chart below shows how a company's share price and consensus price target have changed over time. The dark blue line represents the company's actual price. The lighter blue line represents the stock's consensus price target. The even lighter blue range in the background of the two lines represents the low price target and the high price target for each stock.
Skip Chart and View Analyst Price Target HistorySkip Chart & View Price History Table

Morgan Stanley Stock vs. The Competition

TypeMorgan StanleyFinance CompaniesS&P 500
Consensus Rating Score
2.35
2.51
2.52
Consensus RatingHoldModerate BuyModerate Buy
Predicted Upside-4.92% Downside21.05% Upside11.17% Upside
News Sentiment Rating
Positive News

See Recent MS News
Positive News
Positive News
DateBrokerageAnalyst NameActionRatingPrice TargetUpside/Downside on Report DateDetails
1/21/2025UBS Group
4 of 5 stars
Brennan Hawken
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost TargetNeutral ➝ Neutral$130.00 ➝ $140.00+2.81%
1/17/2025Barclays
3 of 5 stars
Jason Goldberg
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost TargetOverweight ➝ Overweight$155.00 ➝ $156.00+13.27%
1/17/2025Bank of America
3 of 5 stars
Michael Carrier
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost TargetBuy ➝ Buy$146.00 ➝ $153.00+11.43%
1/17/2025Evercore ISI
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Glenn Schorr
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost TargetOutperform ➝ Outperform$140.00 ➝ $150.00+10.15%
1/17/2025Keefe, Bruyette & Woods
Subscribe to MarketBeat All Access for the recommendation accuracy rating
David Konrad
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost TargetMarket Perform ➝ Market Perform$138.00 ➝ $145.00+6.78%
1/13/2025JPMorgan Chase & Co.
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Kian Abouhossein
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost TargetNeutral ➝ Neutral$104.00 ➝ $108.00-12.61%
11/26/2024Hsbc Global Res
Subscribe to MarketBeat All Access for the recommendation accuracy rating
S. Martinez
Subscribe to MarketBeat All Access for the recommendation accuracy rating
DowngradeStrong-Buy ➝ Hold
11/26/2024HSBC
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 DowngradeBuy ➝ Hold$128.00 ➝ $131.00-2.00%
11/25/2024Citigroup
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Boost TargetNeutral ➝ Neutral$105.00 ➝ $135.00+0.52%
11/15/2024Wells Fargo & Company
Subscribe to MarketBeat All Access for the recommendation accuracy rating
M. Mayo
Subscribe to MarketBeat All Access for the recommendation accuracy rating
UpgradeUnderweight ➝ Equal Weight$107.00 ➝ $142.00+7.22%
10/17/2024The Goldman Sachs Group
Subscribe to MarketBeat All Access for the recommendation accuracy rating
R. Ramsden
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost TargetNeutral ➝ Neutral$106.00 ➝ $121.00+0.82%
10/17/2024Royal Bank of Canada
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Boost TargetSector Perform ➝ Sector Perform$108.00 ➝ $122.00+1.66%
10/17/2024Jefferies Financial Group
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Boost TargetBuy ➝ Buy$120.00 ➝ $135.00+12.69%
7/18/2024JMP Securities
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Reiterated RatingMarket Perform
7/18/2024BMO Capital Markets
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Boost TargetOutperform ➝ Outperform$116.00 ➝ $118.00+10.42%
7/17/2024Oppenheimer
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 DowngradeOutperform ➝ Market Perform
4/16/2024Cfra
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Boost TargetBuy ➝ Buy$97.00 ➝ $108.00+20.82%
11/28/2023Societe Generale
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 DowngradeBuy ➝ Hold$80.00+2.63%
11/20/2023BNP Paribas
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 DowngradeOutperform ➝ Neutral$85.00+5.88%
10/23/2023Odeon Capital Group
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 DowngradeBuy ➝ Hold$79.15+8.72%
10/20/2023Wolfe Research
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 UpgradeUnderperform ➝ Peer Perform
8/1/2023Atlantic Securities
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Boost TargetNeutral ➝ Neutral$85.00 ➝ $90.00-1.70%

Analyst ratings data on MarketBeat is provided by Benzinga and other data providers. This page was last refreshed on Wednesday at 02:14 PM ET.


Should I Buy Morgan Stanley Stock? MS Pros and Cons Explained

These pros and cons were generated based on recent news and financial data from MarketBeat in order to provide readers with the fastest and most accurate insights. They were last updated on Monday, January 20, 2025. Please send any questions or comments about these Morgan Stanley pros and cons to contact@marketbeat.com.

Morgan Stanley
Bull Case

green Wall Street bull icon

Here are some ways that investors could benefit from investing in Morgan Stanley:

  • The stock is currently trading at $137.78, reflecting strong market performance and investor confidence.
  • Recent earnings reports show that Morgan Stanley has consistently exceeded analysts' expectations, with a reported EPS of $2.22, significantly higher than the consensus estimate of $1.54.
  • The company has a robust market capitalization of $221.97 billion, indicating its strong position in the financial services sector.
  • Analysts have given an average price target of $129.40, suggesting potential for growth, with several firms recently raising their target prices, indicating positive sentiment.
  • Institutional investors hold 84.19% of the stock, which often indicates confidence in the company's long-term stability and performance.

Morgan Stanley
Bear Case

red Wall Street bear icon

Investors should be bearish about investing in Morgan Stanley for these reasons:

  • The average recommendation from analysts is a "Hold," which may suggest that there is limited upside potential in the near term.
  • The company has a high debt-to-equity ratio of 3.14, indicating that it relies heavily on debt financing, which can be risky in volatile market conditions.
  • Despite recent strong earnings, the stock's price-to-earnings (P/E) ratio of 20.97 may suggest that it is overvalued compared to its earnings growth potential.
  • Market fluctuations and economic uncertainties can impact financial services firms like Morgan Stanley, making it a potentially risky investment.
  • Recent downgrades from some analysts, such as HSBC lowering its rating from "buy" to "hold," may indicate caution among market experts regarding the stock's future performance.

MS Forecast - Frequently Asked Questions

According to the research reports of 17 Wall Street equities research analysts, the average twelve-month stock price forecast for Morgan Stanley is $131.27, with a high forecast of $156.00 and a low forecast of $105.00.

17 Wall Street equities research analysts have issued "buy," "hold," and "sell" ratings for Morgan Stanley in the last year. There are currently 11 hold ratings and 6 buy ratings for the stock. The consensus among Wall Street equities research analysts is that investors should "hold" MS shares. A hold rating indicates that analysts believe investors should maintain any existing positions they have in MS, but not buy additional shares or sell existing shares.

According to analysts, Morgan Stanley's stock has a predicted downside of -3.63% based on their 12-month stock forecasts.

Over the previous 90 days, Morgan Stanley's stock had 2 downgrades and 1 upgrade by analysts.

Morgan Stanley has been rated by research analysts at Bank of America, Barclays, Citigroup, Evercore ISI, Hsbc Global Res, HSBC, JPMorgan Chase & Co., Keefe, Bruyette & Woods, UBS Group, and Wells Fargo & Company in the past 90 days.

Morgan Stanley also publishes sell-side equities research reports and recommendations about other companies, which can be viewed at its brokerage rating page.

Analysts like Morgan Stanley less than other "finance" companies. The consensus rating for Morgan Stanley is Hold while the average consensus rating for "finance" companies is Moderate Buy. Learn more on how MS compares to other companies.


This page (NYSE:MS) was last updated on 1/22/2025 by MarketBeat.com Staff
From Our Partners